Written answers
Tuesday, 24 September 2019
Department of Health
Medicinal Products Reimbursement
Brendan Ryan (Dublin Fingal, Labour)
Link to this: Individually | In context | Oireachtas source
334. To ask the Minister for Health the status of the rolling out of Plenadren as an alternative hydrocortisone therapy here under the HSE drugs schemes in view of the fact it has been approved in the UK, Spain and the United States of America; and if he will make a statement on the matter. [38591/19]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
Kate O'Connell (Dublin Bay South, Fine Gael)
Link to this: Individually | In context | Oireachtas source
335. To ask the Minister for Health the weighting percentages to be used as part of the upcoming HSE FreeStyle Libre review decision making process that will be given to criteria (details supplied); and if he will make a statement on the matter. [38592/19]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
Kate O'Connell (Dublin Bay South, Fine Gael)
Link to this: Individually | In context | Oireachtas source
336. To ask the Minister for Health if the reimbursement dataset will specifically cover only current HSE-funded users of the FreeStyle Libre device; and if the health technology assessment group review will compare just total blood glucose strip usage spend year on year. [38593/19]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
No comments